Antisense oligonucleotide inhibition of cholesteryl ester transfer protein enhances RCT in hyperlipidemic, CETP transgenic, LDLr(−/−) mice

Due to their ability to promote positive effects across all of the lipoprotein classes, cholesteryl ester transfer protein (CETP) inhibitors are currently being developed as therapeutic agents for cardiovascular disease. In these studies, we compared an antisense oligonucleotide (ASO) inhibitor of C...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Bell, Thomas A., Graham, Mark J., Lee, Richard G., Mullick, Adam E., Fu, Wuxia, Norris, Dan, Crooke, Rosanne M.
Format: Artigo
Język:Inglês
Wydane: The American Society for Biochemistry and Molecular Biology 2013
Hasła przedmiotowe:
Research Articles
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3770078/
https://ncbi.nlm.nih.gov/pubmed/23801661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M036509
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy